CCP
HCAT icon

Corient Capital Partners’s Health Catalyst HCAT Stock Holding History

Corient Capital Partners’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$157K Hold
10,805
– – 0.01% 629
2022
Q2 		$157K Buy
+10,805
New +$184K 0.01% 644

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Corient Capital Partners's HCAT Position: Q3 2022 in Review

Corient Capital Partners held its Health Catalyst (HCAT) position steady in Q3 2022 at 10,805 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #629.

Corient Capital Partners first reported a position in HCAT in Q2 2022 and has held it in 2 quarters since. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Corient Capital Partners held 10,805 shares of Health Catalyst worth $157K as of Q3 2022.
  • Corient Capital Partners left its Health Catalyst share count unchanged in Q3 2022.
  • Health Catalyst made up 0.01% of Corient Capital Partners's portfolio in Q3 2022, its #629 holding.
  • Corient Capital Partners first reported a position in Health Catalyst in Q2 2022 and has held it in 2 quarters since.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.